The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00972764
Recruitment Status :
First Posted : September 7, 2009
Last Update Posted : February 5, 2020
Boushahri Clinic Medical Center
Information provided by (Responsible Party):
Mohamed Said El-Sayed, Boushahri Clinic Medical Center
The purpose of this study is to expose some of the factors that may be associated or predisposing to development of laryngomalacia.
Condition or disease
Laryngomalacia is the most common congenital malformation of the larynx and it is a self-limited disorder. It is the most common cause of stridor in newborns and infants. It results from an abnormal prolapse of supraglottic structures during inspiration. Despite its widespread prevalence, the etiology of laryngomalacia is unclear. Most infants will squeaky but otherwise well. Although affected patients do not exhibit much in the way of other physical symptoms, the unusual voice is worrisome to their parents.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
up to 2 Years (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Primary care clinics
Babies delivered with laryngomalacia with ≥ 37 weeks of gestation